The chemical class termed AIP5 Activators comprises a speculative group of compounds hypothesized to indirectly influence the AIP5 protein and its associated pathways. These compounds operate by affecting various aspects of cytoskeletal dynamics and cell structure, which are critical for the functions where AIP5 might be involved. Compounds like Jasplakinolide, Cytochalasin D, Latrunculin A, and Phalloidin affect the actin cytoskeleton by either stabilizing or disrupting actin filaments. These modifications in the actin network could potentially influence AIP5, particularly in the context of its potential role in actin dynamics and cell motility.
Additionally, compounds like Y-27632, Blebbistatin, ML-7, and Wiskostatin, which modulate the activity of proteins involved in actin-myosin interactions and cytoskeletal organization, provide another indirect route through which AIP5 function might be modulated. These compounds affect cellular mechanics and the organization of the cytoskeletal network, aspects that are likely crucial for AIP5's potential functions.Moreover, inhibitors of the Arp2/3 complex and cofilin, as well as compounds that affect microtubule dynamics like Nocodazole and Paclitaxel, could potentially modulate AIP5 activity. The alteration of actin filament branching, turnover, and the interplay between actin filaments and microtubules represent additional pathways through which AIP5 might be indirectly influenced.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, potentially influencing AIP5 indirectly by affecting the cytoskeletal network and actin dynamics. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, potentially affecting AIP5 activity by altering actin cytoskeleton dynamics. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers, preventing polymerization, which could indirectly affect AIP5 by altering actin dynamics and structure. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Binds and stabilizes actin filaments, potentially influencing AIP5 indirectly through its impact on the cytoskeletal network. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, which could indirectly affect AIP5 through its role in actin cytoskeleton organization and cell motility. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits myosin II, potentially affecting AIP5 indirectly through changes in cellular mechanics and cytoskeletal interactions. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
An inhibitor of myosin light chain kinase, which could indirectly influence AIP5 by affecting actin-myosin interactions and cytoskeletal dynamics. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
An Arp2/3 complex inhibitor, potentially influencing AIP5 activity indirectly by affecting actin filament branching and network formation. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibits N-WASP, affecting actin cytoskeletal dynamics and potentially influencing AIP5 activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule dynamics, potentially affecting AIP5 indirectly through altered cytoskeletal interactions and cellular mechanics. | ||||||